Urinary incontinence in men: current and developing therapy options

Expert Opinion on Pharmacotherapy
Helena Burden, Paul Abrams

Abstract

Urinary incontinence in men is a significant and often underappreciated problem. Men can have urgency and or stress incontinence. Urgency incontinence as part of the overactive bladder (OAB) syndrome and can often coexist with benign prostatic obstruction (BPO) in men and the initial treatment of this is conservative lifestyle changes and then medical therapy. This literature review aims to cover synthetic drugs currently utilised to treat urinary incontinence in men that are phase III and onwards. Neurological incontinence and surgical treatment options for male urinary incontinence are beyond the scope of this review. The most common form of urinary incontinence in men is urgency incontinence secondary to an OAB, which often co-exists in men, with bladder outflow obstruction (BOO). The pharmacotherapy options to treat OAB include antimuscarinics, β3 agonists and phosphodiesterase inhibitors. Antimuscarinics and β3 agonists are effective in treating OAB, and have been found to have no increased urinary retention risk in the group of patients with co-existing BPO. Emerging medications include the alternative β3 agonists - solabegron and ritobegron. The future may include novel combinations of these therapies.

References

Apr 9, 1986·European Journal of Pharmacology·L Nilvebrant, B Sparf
Dec 4, 1982·Lancet·M P CaulfieldN J Birdsall
Jun 9, 1998·Drugs·C J HillsJ A Balfour
Oct 17, 1998·World Journal of Urology·J W ThüroffE A Tanagho
Jun 6, 2000·International Journal of Clinical Pharmacology and Therapeutics·I Füsgen, D Hauri
Apr 27, 2001·Mayo Clinic Proceedings·R A AppellUNKNOWN Overactive Bladder: Judging Effective Control and Treatment Study Group
May 6, 2004·The Journal of Urology·Norman ZinnerUNKNOWN Trospium Study Group
Aug 20, 2004·Journal of Clinical Pharmacology·Ronald A SmuldersMoses Huang
Nov 16, 2006·JAMA : the Journal of the American Medical Association·Steven A KaplanZhonghong Guan
Oct 10, 2007·BJU International·Paul Abrams, Karl-Erik Andersson
Nov 13, 2008·International Journal of Clinical Pharmacology and Therapeutics·B MalhotraK Gandelman
Jan 27, 2009·Journal of the American Geriatrics Society·Toine A L M Lagro-JanssenDoreth Teunissen
May 27, 2010·International Journal of Clinical Practice·T SchneiderM C Michel
Apr 20, 2011·The Journal of Obstetrics and Gynaecology Research·Sheng-Mou HsiaoHo-Hsiung Lin
Nov 11, 2011·CNS Neuroscience & Therapeutics·Michael Chancellor, Timothy Boone
Nov 19, 2011·Journal of the American Geriatrics Society·Kathryn L BurgioDavid T Redden
Feb 9, 2012·International Urogynecology Journal·Deyi LuoHong Shen
Apr 19, 2012·The Journal of Pharmacology and Experimental Therapeutics·Itaru MaruyamaHiroshi Kusama

❮ Previous
Next ❯

Citations

May 15, 2018·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Elizabeth T ChorneyEvan S Siegelman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.